GCP
ZY

GSA Capital Partners’s Zymergen Inc. Common Stock ZY Stock Holding History

GSA Capital Partners’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-47,264
Closed -$58K – 2005
2022
Q2 		$58K Buy
+47,264
New +$79.2K 0.01% 1274

Other funds holding ZY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

GSA Capital Partners's ZY Position: Q3 2022 in Review

GSA Capital Partners sold out of Zymergen Inc. Common Stock (ZY) in Q3 2022, closing a stake of 47,264 shares — an estimated $58K sold.

GSA Capital Partners first reported a position in ZY in Q2 2022 and held it in 1 quarter. The position peaked at $58K in Q2 2022. 86 funds tracked by Wall St. Rank hold ZY as of Q3 2022.

  • GSA Capital Partners reported no remaining Zymergen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • GSA Capital Partners sold 47,264 Zymergen Inc. Common Stock shares in Q3 2022, an estimated $58K.
  • GSA Capital Partners first reported a position in Zymergen Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • GSA Capital Partners's Zymergen Inc. Common Stock position peaked at $58K in Q2 2022.
  • 86 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q3 2022.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.